The Korea Fund, Inc. (NYSE:KF) Brief Interest Update

The Korea Fund, Inc. (NYSE:KF) saw significant short interest growth in the month of December. As of December 31, there were short interests totaling 7,400 shares, a growth of 76.2% from the total of 4,200 shares as of December 15. Based on an average daily volume of 8,600 shares, the short interest ratio is currently 0.9 days.

KF opened at $34.75 on Friday. The company’s 50-day moving average is $38.57 and its 200-day moving average is $41.44. The Korean Fund has a 52-week low of $33.05 and a 52-week high of $46.88.

The company also recently declared an annual dividend, which was paid on Monday, January 10. Investors of record on Monday, December 27 received a dividend of $2,045. This represents a dividend yield of 4.86%. The ex-dividend date was Thursday, December 23. This is a positive change from the Korea Fund’s previous annual dividend of $0.53.

Large investors have recently changed their stock holdings. City of London Investment Management Co. Ltd. increased its stake in Korea Fund shares by 0.4% in the second quarter. City of London Investment Management Co. Ltd. now owns 1,862,825 shares of the company worth $86,463,000 after purchasing an additional 8,100 shares in the last quarter. Wells Fargo & Company MN increased its stake in The Korea Fund by 6.3% during the second quarter. Wells Fargo & Company MN now owns 266,208 shares of the company valued at $12,287,000 after purchasing an additional 15,703 shares in the last quarter. Royal Bank of Canada increased its stake in The Korea Fund by 7.6% during the third quarter. Royal Bank of Canada now owns 31,311 shares of the company valued at $1,282,000 after buying 2,209 more shares in the last quarter. UBS Group AG increased its stake in The Korea Fund by 109.3% during the third quarter. UBS Group AG now owns 1,350 shares of the company valued at $56,000 after buying an additional 705 shares in the last quarter. Finally, First Foundation Advisors purchased a new stake in The Korea Fund during the second quarter at a value of $208,000. Institutional investors and hedge funds hold 56.90% of the company’s shares.

(A d)

Big pharma, financial institutions and wealthy businessmen have all invested hundreds of millions in this venture…

They make these big investments because it’s a huge opportunity.

About the Korea Fund

The Korea Fund, Inc operates as a non-diversified closed-end investment fund. The Company intends to seek long-term capital appreciation by investing in securities. It invests in various industries, such as chemicals, commercial banking, business services and supplies, communications, construction and engineering, consumer discretionary, consumer credit, diversified consumer services, electrical equipment, electronic equipment and instruments, entertainment, financial services, food and basic necessities. retail, insurance, software and Internet services, metals and mining, pharmaceuticals, retail, semiconductors, shipbuilding, tobacco, wholesale and wireless telecommunications services.

Recommended Story: What is the Nikkei 225 Index?

This instant news alert was powered by MarketBeat’s storytelling science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]

Should you invest $1,000 in The Korea Fund right now?

Before you consider The Korea Fund, you’ll want to hear this.

MarketBeat tracks daily the highest rated and most successful research analysts on Wall Street and the stocks they recommend to their clients. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market ripples…and the Korea Fund was not on the list.

While the Korea Fund currently has an “N/A” rating among analysts, top-rated analysts believe these five stocks are better buys.

See the 5 actions here

About Emilie Brandow

Check Also

Medimaps Group Announces Partnership with OsteoSys to Bring Trabecular Bone Score to Korea’s Leading Bone Densitometry Platform

GENEVA, November 14, 2022–(BUSINESS WIRE)–MEDIMAPS GROUP (, a Swiss/global medical technology company specializing in image …